NIH has released new solicitations related to the reauthorized SBIR program.
June 8, 2026
Commercialization Support
June 8, 2026
Proposed regulation would require senior agency approval before federal research awards are issued
A newly proposed federal regulation could affect how research grants are awarded to small businesses and other recipients.
April 20, 2026
An overview of the ART program at DoW
The Accelerated Research for Transition (ART) program is a Department of War (DoW) initiative designed to help promising SBIR/STTR technologies transition from research into actual military use.
March 10, 2026
SBIR/STTR Alternative: Long Range Broad Agency Announcements (LRBAAs)
Several federal agencies are actively accepting submissions through Long Range Broad Agency Announcements (LRBAAs).
February 24, 2026
NIH Funding Priorities
While we’re all very aware of the challenges tied to the reauthorization process, I also want to keep an eye on topics that matter for the long term— especially for those putting together SBIR proposals in the future.
January 2, 2026
Successful Business Transitioning Characteristics
I was recently asked “What distinguishes SBIR/STTR companies that successfully transition into investor-ready ventures? Are there certain characteristics?” Here are a couple of points that struck me right away.
January 2, 2026
Foreign Risk vs. SBA Red Tape Hotline
This summer we posted about the unfortunate circumstances some of our NIH applicants have had with failing to pass the foreign risk assessment.
January 2, 2026
Is your innovation right for Army FUZE?
The Defense TechConnect Innovation Summit, in conjunction with the SBIR/STTR Fall Innovation Conference was recently held in National Harbor.
September 17, 2025
Celebrating Innovation: Highlights from the SBIR Advance 10th Anniversary Showcase
On Thursday, September 11th, we gathered to celebrate the achievements of Wisconsin’s top tech entrepreneurs at the SBIR Advance 10th Anniversary Showcase.
August 29, 2025
NIH Applications rejected for failing Foreign Risk Assessment
Recently we have had numerous NIH SBIR/STTR proposals rejected because they have failed the foreign risk assessment.